A pilot study to measure the clearance of replication-competent HIV-1 in resting memory CD4+ cells in HIV-1-infected subjects who receive enfuvirtide [Fuzeon (Rm)] plus oral combination antiretroviral therapy.
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2013
At a glance
- Drugs Enfuvirtide (Primary) ; Emtricitabine; Ritonavir; Saquinavir; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Apr 2012 Actual end date changed from Apr 2009 to May 2008 as reported by ClinicalTrials.gov.
- 06 Apr 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.